This Day in History: FDA Announces Approval of Fuzeon-March 13, 2003
In 2003, the FDA approved Fuzeon, a new drug used to fight the HIV virus. It was the first drug approved in a new class of HIV medications called “fusion inhibitors.” These drugs interfere with the entry of the virus into the cells. Basically, the drug prohibited the virus’s progression by eliminating the first step of viral infiltration.
The drug was a breakthrough medication, and was approved to be used as part of existing combination therapies in adults and children. The approval of the drug was particularly important because Fuzeon was used in patients who had limited treatment options due to medication intolerance or resistance issues.
These milestones are important because each one has paved the way for the progress we have experienced so rapidly over the past two to three years. Check out the original press release at http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm125088.htm
For more information about ARE’s services, or to learn how you can help, contact Janet Tinkham at 540-536-5293. This post has been provided by ARE volunteer Victoria Kidd, freelance writer, certified professional résumé writer, and owner of OMP Consulting Group. (Visit www.ompcg.com to learn more about our business blogging or personal résumé writing services.)
Tagged 2003, aids meds, breakthrough medication, FDA, Federal Drug Admistration, fusion inhibitors, Fuzeon, HIV, hiv medications, March 13, medication intolerance, resistance issues, viral infiltration